Pierre BOULUD

About Pierre BOULUD

Pierre Boulud is the Chief Executive Officer of bioMérieux, the French listed leader in in vitro diagnostics. He assumed the CEO role on July 1, 2023, following a governance change that separated the roles of Executive Chairman and Chief Executive Officer. In this structure, he leads the Executive Committee and is responsible for executing the company’s strategy across all dimensions, working alongside Executive Chairman Alexandre Mérieux. Before becoming CEO, Pierre Boulud served as Chief Operating Officer of bioMérieux for about three years and had already been a member of the Executive Committee for seven years. He joined bioMérieux in November 2016 as Corporate Vice President for the Asia Pacific region, a role that also placed him in charge of the group’s portfolio management and strategic planning starting in January 2017. Those responsibilities gave him direct exposure to international growth, portfolio allocation and long-term strategic execution. His earlier career spans both consulting and pharmaceuticals. Prior to joining bioMérieux, he spent 14 years at Ipsen, where he held several senior positions, including head of Strategy and Business Development and later Executive Vice President in charge of Specialty Care Commercial Operations. Earlier still, he spent five years at Boston Consulting Group and began his career in 1995 at Bossard Consultants. This background reflects a strong combination of strategic advisory skills, business development expertise and operational leadership. Pierre Boulud holds an MBA from ESSEC Business School. At bioMérieux, he has overseen key strategic milestones, including the launch of the GO•28 five-year plan in 2024, positioned as a new chapter for profitable and sustainable growth, and the company’s subsequent execution updates showing performance ahead of plan ambitions. His leadership is centered on innovation, international expansion, portfolio optimization and long-term value creation for a global diagnostics platform.